SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-14-000093
Filing Date
2014-03-14
Accepted
2014-03-14 12:03:34
Documents
8
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED DECEMBER 31, 2013 nymox6kar131231.htm 6-K 5468
2 ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2013 exhibit99-1.htm EX-99.1 656496
3 SOX SECTION 302 AND 906 CEO CERTIFICATIONS exhibit99-2.htm EX-99.2 6353
4 SOX SECTION 302 AND 906 CFO CERTIFICATIONS exhibit99-3.htm EX-99.3 6300
5 exhibit99-1p1x1x1.jpg GRAPHIC 11751
6 kpmglogo.jpg GRAPHIC 7883
7 kpmgsig.jpg GRAPHIC 5715
8 kpmgsmalllogo.jpg GRAPHIC 3551
  Complete submission text file 0001176256-14-000093.txt   715971
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 14693450
SIC: 2835 In Vitro & In Vivo Diagnostic Substances